Tuesday, July 22, 2008 7:46:40 PM
This company seems to be legit. While I'm not expecting a run to $1, I think it is reasonable to expect $0.01 to $0.03 in the short term. This would yield somewhere between a $5M and $15M market cap. For a company saying that they just landed a $22M deal, this looks very reasonable to me.
I'd look for a strengthening of the share price into the last half of the week as long as the congressional visit stays on track. I'd also expect an announcement of the $22M JV partner either right before, or in conjuction with Congresswoman Foxx's visit on Monday. Assuming those things happen I wouldn't be at all surprised to see the share price somewhere between $0.01-0.02 by market close that day.
All IMO. GLTA,
Murocman
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM